Learn
Medical EducationEvidence-Based MedicinePatient Education
ICU Toolkit
CalculatorsProtocols & CardsICU Setup
CPT & BillingZad TalkForumContact
Home / Calculators / Vasoactive-Inotropic Score (VIS) Calculator

Vasoactive-Inotropic Score (VIS) Calculator

Adds vasopressor and inotrope doses into one number, the vasoactive-inotropic score (VIS), and shows norepinephrine equivalents. Used to describe and follow the intensity of drug support in cardiogenic shock and after cardiac surgery.

Vasopressors

µg/kg/min
µg/kg/min
µg/kg/min
ng/kg/min

Inotropes

µg/kg/min
µg/kg/min
µg/kg/min
Vasoactive-Inotropic Score
Fill in the fields above to see the result.

How to read the result

Maximum VIS, first 48 hoursIn-hospital mortality
1-108.2%
11-2014.1%
21-3821.1%
39-8532.0%
Above 8565.7%

These are the quintiles of 493 patients with cardiogenic shock in one Korean cardiac ICU (Na 2018). In 3,665 patients with cardiogenic shock in the North American CCCTN registry, cardiac ICU mortality rose from 13% with a VIS below 10 to 45% with a VIS of 40 or more at 4 hours, and from 11% to 73% at 24 hours. A rise of 10 points or more between 4 and 24 hours carried 2 to more than 4 times the mortality of a fall of 10 points or more. The CCCTN version adds 10 × phenylephrine, shown separately when phenylephrine is entered. The VIS does not count mechanical support, and each 10-point rise in VIS carried less added risk in patients on a device (odds ratio 1.36 vs 1.84 at 24 hours).

Formula

ValueFormula
VISDopamine + dobutamine + 100 × epinephrine + 10 × milrinone + 10,000 × vasopressin (U/kg/min) + 100 × norepinephrine (other doses in µg/kg/min)
VIS with phenylephrine (CCCTN)VIS + 10 × phenylephrine (µg/kg/min)
Norepinephrine equivalents (µg/kg/min)Norepinephrine + epinephrine + dopamine / 100 + 0.06 × phenylephrine + 2.5 × vasopressin (U/min) + 0.0025 × angiotensin II (ng/kg/min)

Vasopressin is usually charted in U/min or U/h; the VIS needs U/kg/min, so the calculator divides by weight (0.04 U/min in an 80 kg patient is 0.0005 U/kg/min, or 5 VIS points). Doses charted in µg/min are converted with the weight. Both formulas are generally read as norepinephrine base, the way US products are labelled, though the Kotani authors note it is unknown whether earlier scores meant base or salt. A dose labelled as a salt contains less base: divide a tartrate dose by 2, a bitartrate dose by 1.89 and a hydrochloride dose by 1.22. The norepinephrine-equivalent formula is a proposed conversion built from published dose comparisons and has not been validated against outcomes; dobutamine and milrinone carry no norepinephrine equivalent.

Validation

The VIS was introduced in 174 infants after cardiopulmonary bypass, where a high maximum score in the first 48 hours predicted death, cardiac arrest, mechanical support, renal replacement therapy or neurologic injury. In 3,213 adults after cardiac surgery, the maximum VIS in the first 24 hours predicted 30-day mortality with an AUC of 0.76. In adult cardiogenic shock it has been studied as the maximum over the first 48 hours (Na 2018) and at 4 and 24 hours (CCCTN), where the change between the two improved the mortality discrimination of the SOFA score and the SCAI stage.

References

  1. Gaies MG, Gurney JG, Yen AH, et al. Vasoactive-inotropic score as a predictor of morbidity and mortality in infants after cardiopulmonary bypass. Pediatr Crit Care Med. 2010;11(2):234-238. PMID 19794327
  2. Gaies MG, Jeffries HE, Niebler RA, et al. Vasoactive-inotropic score is associated with outcome after infant cardiac surgery: an analysis from the Pediatric Cardiac Critical Care Consortium and Virtual PICU System Registries. Pediatr Crit Care Med. 2014;15(6):529-537. PMID 24777300
  3. Koponen T, Karttunen J, Musialowicz T, et al. Vasoactive-inotropic score and the prediction of morbidity and mortality after cardiac surgery. Br J Anaesth. 2019;122(4):428-436. PMID 30857599
  4. Na SJ, Chung CR, Cho YH, et al. Vasoactive inotropic score as a predictor of mortality in adult patients with cardiogenic shock: medical therapy versus ECMO. Rev Esp Cardiol (Engl Ed). 2019;72(1):40-47. PMID 29463462
  5. Patel SM, Berg DD, Bohula EA, et al. Early serial assessment of aggregate vasoactive support and mortality in cardiogenic shock: insights from the Critical Care Cardiology Trials Network registry. Circ Heart Fail. 2024;17(5):e011736. PMID 38587438
  6. Kotani Y, Di Gioia A, Landoni G, et al. An updated "norepinephrine equivalent" score in intensive care as a marker of shock severity. Crit Care. 2023;27(1):29. PMID 36670410
  7. Kotani Y, Landoni G, Belletti A, et al. Response to: norepinephrine formulation for equivalent vasopressive score. Crit Care. 2023;27(1):125. PMID 36978126
  8. Wieruszewski PM, Leone M, Kaas-Hansen BS, et al. Position paper on the reporting of norepinephrine formulations in critical care from the Society of Critical Care Medicine and European Society of Intensive Care Medicine Joint Task Force. Crit Care Med. 2024;52(4):521-530. PMID 38240498
  9. Morales S, Wendel-Garcia PD, Ibarra-Estrada M, et al. The impact of norepinephrine dose reporting heterogeneity on mortality prediction in septic shock patients. Crit Care. 2024;28(1):216. PMID 38961499
Keep reading

Related articles

All Cardiovascular →

Standardized Team-Based Care for Cardiogenic Shock

BACKGROUND Cardiogenic shock (CS) is a multifactorial, hemodynamically complex syndrome associated with high mortality. Despite advances in reperfusion and mechanical circulatory support, management remains highly variable and out…

October 4, 2022